Clinical Account Executive, Central PA

Pennsylvania, United States

Apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Technology, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in a related field, along with a strong understanding of oncology, hematology, chemotherapeutics, and targeted agents. They should also demonstrate excellent negotiation and customer service skills, a very positive attitude, and the ability to handle sensitive information with confidentiality. Furthermore, proficiency in Microsoft Office products, particularly Excel and PowerPoint, and experience with Salesforce.com are required, as well as the ability to provide an integrated MolDx/SaaS solution using Tempus’ sequencing technology.

Responsibilities

The Clinical Account Executive will drive strategic business expansion and collaboration opportunities with cancer centers, oncology practices, KOLs, and AMCs within Central PA, structuring strategic plans for client acquisition and retention. They will maximize client-bill contracting opportunities, implement laboratory services agreements, collaborate with sales teams, identify partnering opportunities, promote compliance with new tools, monitor performance, develop business plans, and work effectively with various departments. The role also involves analyzing the competitive landscape, providing customer feedback, and maintaining a comprehensive understanding of the payor and reimbursement environment, as well as frequent travel to assigned territories.

Skills

oncology

sales strategy

client relationship management

laboratory services agreements

web-based molecular information tools

collaborative coordination

competitive landscape analysis

territory management

business planning

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees